Evidence map›Paper›PMID 38976869›Full record

ArticleJMIR aging2024

Self-Explainable Graph Neural Network for Alzheimer Disease and Related Dementias Risk Prediction: Algorithm Development and Validation Study.

Xinyue Hu, Zenan Sun, Yi Nian, Yichen Wang, Yifang Dang, Fang Li, Jingna Feng, Evan Yu, Cui Tao

Abstract readValidation Study
In one paragraph

Article in JMIR aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinyue Hu *Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, United States.ORCID 0009-0006-2685-951X
Zenan Sun *McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0003-1577-874X
Yi NianMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0002-4387-5574
Yichen WangDivision of Hospital Medicine at Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, United States.ORCID 0000-0003-0723-5913
Yifang DangMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0002-4014-2957
Fang LiDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, United States.ORCID 0000-0001-8865-7717
Jingna FengDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, United States.ORCID 0000-0002-0434-2513
Evan YuMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0001-9135-3757
Cui TaoDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, United States.ORCID 0000-0002-4267-1924

Funding

TRAINING PROGRAM IN COMPUTATIONAL BIOLOGY AND MEDICINET15LM007093 · NLM · RICE UNIVERSITY · PI Lydia E. Kavraki · 1992 to 2026
$20.8M
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation SystemR01AG084236 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Jiang Bian, Cui Tao · 2023 to 2026
$4.1M
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health recordsR01AG083039 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BIAN, JIANG, JIANG, XIAOQIAN · 2023 to 2025
$3.4M
Facilitate Observational Studies of Alzheimer's Disease and Alzheimer's Disease-Related Dementias Using Ontology and Natural Language ProcessingRF1AG072799 · NIA · YALE UNIVERSITY · PI LIU, HONGFANG, TAO, CUI · 2021 to 2021
$2.4M
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRDR56AG074604 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, TAO, CUI · 2021 to 2022
$1.5M
NIA NIH HHS R01 AG083039NIA NIH HHS R01 AG084236NIA NIH HHS R56 AG074604NIA NIH HHS RF1 AG072799NLM NIH HHS T15 LM007093
6 · The paper itself

Abstract

backgroundAlzheimer disease and related dementias (ADRD) rank as the sixth leading cause of death in the United States, underlining the importance of accurate ADRD risk prediction. While recent advancements in ADRD risk prediction have primarily relied on imaging analysis, not all patients undergo medical imaging before an ADRD diagnosis. Merging machine learning with claims data can reveal additional risk factors and uncover interconnections among diverse medical codes.

objectiveThe study aims to use graph neural networks (GNNs) with claim data for ADRD risk prediction. Addressing the lack of human-interpretable reasons behind these predictions, we introduce an innovative, self-explainable method to evaluate relationship importance and its influence on ADRD risk prediction.

methodsWe used a variationally regularized encoder-decoder GNN (variational GNN [VGNN]) integrated with our proposed relation importance method for estimating ADRD likelihood. This self-explainable method can provide a feature-important explanation in the context of ADRD risk prediction, leveraging relational information within a graph. Three scenarios with 1-year, 2-year, and 3-year prediction windows were created to assess the model's efficiency, respectively. Random forest (RF) and light gradient boost machine (LGBM) were used as baselines. By using this method, we further clarify the key relationships for ADRD risk prediction.

resultsIn scenario 1, the VGNN model showed area under the receiver operating characteristic (AUROC) scores of 0.7272 and 0.7480 for the small subset and the matched cohort data set. It outperforms RF and LGBM by 10.6% and 9.1%, respectively, on average. In scenario 2, it achieved AUROC scores of 0.7125 and 0.7281, surpassing the other models by 10.5% and 8.9%, respectively. Similarly, in scenario 3, AUROC scores of 0.7001 and 0.7187 were obtained, exceeding 10.1% and 8.5% than the baseline models, respectively. These results clearly demonstrate the significant superiority of the graph-based approach over the tree-based models (RF and LGBM) in predicting ADRD. Furthermore, the integration of the VGNN model and our relation importance interpretation could provide valuable insight into paired factors that may contribute to or delay ADRD progression.

conclusionsUsing our innovative self-explainable method with claims data enhances ADRD risk prediction and provides insights into the impact of interconnected medical code relationships. This methodology not only enables ADRD risk modeling but also shows potential for other image analysis predictions using claims data.

Indexed as

Alzheimer DiseaseNeural Networks, ComputerAgedAlgorithmsDementiaFemaleHumansMachine LearningMaleRisk AssessmentRisk FactorsAlzheimer disease and related dementiasgraph neural networkmachine learningrelation importancerisk prediction

Identifiers

PMID38976869
PMCPMC11263893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.